| المؤلفون: |
Christo SN; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia; email: susan.christo@unimelb.edu.au, lkmackay@unimelb.edu.au., Park SL; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia; email: susan.christo@unimelb.edu.au, lkmackay@unimelb.edu.au.; Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Mueller SN; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia; email: susan.christo@unimelb.edu.au, lkmackay@unimelb.edu.au., Mackay LK; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia; email: susan.christo@unimelb.edu.au, lkmackay@unimelb.edu.au. |
| مستخلص: |
Regionalized immune surveillance relies on the concerted efforts of diverse memory T cell populations. Of these, tissue-resident memory T (T RM ) cells are strategically positioned in barrier tissues, where they enable efficient frontline defense against infections and cancer. However, the long-term persistence of these cells has been implicated in a variety of immune-mediated pathologies. Consequently, modulating T RM cell populations represents an attractive strategy for novel vaccination and therapeutic interventions against tissue-based diseases. Here, we provide an updated overview of T RM cell heterogeneity and function across tissues and disease states. We discuss mechanisms of T RM cell-mediated immune protection and their potential contributions to autoimmune disorders. Finally, we examine how T RM cell responses might be durably boosted or dampened for therapeutic gain. |
